Author:
Lv Huakun,Wang Shenyu,Liang Zhenzhen,Yu Wei,Yan Chuanfu,Chen Yingping,Hu Xiaosong,Fu Rong,Zheng Minghuan,Group Thomas,Luxembourg Alain,Liao Xueyan,Chen Zhiping
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference45 articles.
1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis;de Martel;Lancet Glob Health,2020
2. 9-valent human papillomavirus vaccine: a review of the clinical development program;Luxembourg;Expert Rev Vaccines,2017
3. Xiamen Innovax Biotech CO., LTD. NMPA announce the approval to bivalent HPV vaccine type 16 & 18 (Cecolin®); 2019.
4. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease;Serrano;Infect Agent Cancer,2012
5. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, et al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in China. Summary Report. ICO Information Centre on HPV and Cancer (HPV Information Centre); 2019.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献